Inotek Pharma (ITEK) Reports Q1 Loss of $0.38

Inotek Pharma (NASDAQ: ITEK) reported Q1 EPS of ($0.38), versus ($0.21) reported last year.

For earnings history and earnings-related data on Inotek Pharma (ITEK) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance